PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcneulBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Neurology
 
BMC Neurol. 2007; 7: 5.
Published online 2007 February 28. doi:  10.1186/1471-2377-7-5
PMCID: PMC1810309
Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production
Hedley CA Emsley,corresponding author1 Craig J Smith,2 Carole M Gavin,3 Rachel F Georgiou,2 Andy Vail,4 Elisa M Barberan,5 Karen Illingworth,6 Sylvia Scarth,6 Vijitha Wickramasinghe,7 Margaret E Hoadley,6 Nancy J Rothwell,7 Pippa J Tyrrell,2 and Stephen J Hopkins6
1Division of Neuroscience, The University of Liverpool, The Walton Centre for Neurology & Neurosurgery, Lower Lane, Liverpool L9 7LJ, UK
2Division of Medicine and Neuroscience, The University of Manchester, Hope Hospital, Salford, UK
3Department of Emergency Medicine, Hope Hospital, Salford, UK
4Biostatistics Group, The University of Manchester, Hope Hospital, Salford, UK
5Stroke Medicine (Neurosciences), Hope Hospital, Salford, UK
6Injury Research, Hope Hospital, Salford, UK
7Faculty of Life Sciences, The University of Manchester, UK
corresponding authorCorresponding author.
Hedley CA Emsley: h.emsley/at/liv.ac.uk; Craig J Smith: csmith/at/fs1.ho.man.ac.uk; Carole M Gavin: carole.gavin/at/srht.nhs.uk; Rachel F Georgiou: rachel.georgiou/at/manchester.ac.uk; Andy Vail: avail/at/fs1.ho.man.ac.uk; Elisa M Barberan: elisa.barberan/at/srht.nhs.uk; Karen Illingworth: kareni/at/fs1.ho.man.ac.uk; Sylvia Scarth: sscarth/at/fs1.ho.man.ac.uk; Vijitha Wickramasinghe: vijithaw/at/aol.com; Margaret E Hoadley: mhoadley/at/fs1.ho.man.ac.uk; Nancy J Rothwell: nancy.rothwell/at/manchester.ac.uk; Pippa J Tyrrell: pippa.tyrrell/at/hope.man.ac.uk; Stephen J Hopkins: steve.hopkins/at/manchester.ac.uk
Received August 11, 2006; Accepted February 28, 2007.
Abstract
Background
As critical mediators of local and systemic inflammatory responses, cytokines are produced in the brain following ischaemic stroke. Some have been detected in the circulation of stroke patients, but their role and source is unclear. Focusing primarily on interleukin(IL)-1-related mechanisms, we serially measured plasma inflammatory markers, and the production of cytokines by whole blood, from 36 patients recruited within 12 h and followed up to 1 year after acute ischaemic stroke (AIS).
Results
Admission plasma IL-1 receptor antagonist (IL-1ra) concentration was elevated, relative to age-, sex-, and atherosclerosis-matched controls. IL-1β, soluble IL-1 receptor type II, tumour necrosis factor (TNF)-α, TNF-RII, IL-10 and leptin concentrations did not significantly differ from controls, but peak soluble TNF receptor type I (sTNF-RI) in the first week correlated strongly with computed tomography infarct volume at 5–7 days, mRS and BI at 3 and 12 months. Neopterin was raised in patients at 5–7 d, relative to controls, and in subjects with significant atherosclerosis. Spontaneous IL-1β, TNF-α and IL-6 gene and protein expression by blood cells was minimal, and induction of these cytokines by lipopolysaccharide (LPS) was significantly lower in patients than in controls during the first week. Minimum LPS-induced cytokine production correlated strongly with mRS and BI, and also with plasma cortisol.
Conclusion
Absence of spontaneous whole blood gene activation or cytokine production suggests that peripheral blood cells are not the source of cytokines measured in plasma after AIS. Increased plasma IL-1ra within 12 h of AIS onset, the relationship between sTNF-RI and stroke severity, and suppressed cytokine induction suggests early activation of endogenous immunosuppressive mechanisms after AIS.
Articles from BMC Neurology are provided here courtesy of
BioMed Central